Novo Nordisk files for FDA approval of CagriSema, the first once weekly combination of GLP1 and amylin analogues for weight management Good looking results for Novo Nordisk's combo of GLP1ra semaglutide (known as #ozempic for #diabetes & #wegovy for obesity) + Cagrilintide (amylin agonist) to achieve #weightloss in obesity and obesity with type Wellness peptide craze: why people are injecting drugs 'not for human consumption' Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Before vs. after 3 months of GHK Cu peptide therapy smoother texture, more even tone, and skin that looks healthier overall. Small peptide, big difference Cagrilintide Lumin Peptides